2021 CMSC Annual Meeting

Tag: (1)Neurology

Poster-Symptom Management

Symptom Burden and Treatment Goals of People with MS Spasticity: Results from SEEN-MSS, a Large-Scale, Self-Reported Survey

Background: Evidence suggests that people with multiple sclerosis and spasticity (pwMSS) experience multiple concurrent symptoms that...

Read More

Poster-Symptom Management

The Effect of Hypnotics and Stimulants on Fatigue, Sleep, and Quality of Life Outcomes in a Multiple Sclerosis Cohort

Background: Sleep disturbance in persons with multiple sclerosis (pwMS) is associated with fatigue, depression, future cognitive decline,...

Read More

Poster-Quality of Life and Outcomes

Multiple Sclerosis Specialist Nurse Care: Patterns of Access and Impact on Health Outcomes

Background: Multiple Sclerosis (MS) specialist nurses are an integral part of the multidisciplinary health care team of people with MS....

Read More

Poster-Quality of Life and Outcomes

Adherence to Oral Disease Modifying Therapies in Clinical Practice and Patient-Centered Outcomes

Background: There are more than 20 disease modifying therapies (DMTs) approved for treatment of Multiple Sclerosis. Previous studies in the...

Read More

Poster-Programs

Impact of a Virtual Wellness Program on Quality-of-Life Measures for Patients Living with MS during the COVID-19 Pandemic

Background: Patients with MS are vulnerable to the effects of lack of physical activity caused by stay-at-home orders with the …...

Read More

Poster-Neuroimmunology and disease models

Mucosal Associated Invariant T (MAIT) Cells Show Defective Activation in People with Multiple Sclerosis

Background: mucosal associated invariant T (MAIT) cells are innate-like T cells expressing an invariant TCR ? chain with a limited …...

Read More

Poster-Imaging

Could Cerebral Autoregulatory Collapse Explain Cognitive Impairment in MS?

Background: Cognitive impairment occurs in almost 70% of multiple sclerosis (MS) patients. The pathophysiology of this impairment is...

Read More

Poster-Epidemiology and Genetics

Population-Based Incidence and Clinico-Radiological Characteristics of Tumefactive Multiple Sclerosis in Olmsted County, Minnesota, USA

Background: Tumefactive multiple sclerosis (TMS) is a rare variant of multiple sclerosis presenting with large inflammatory lesions that...

Read More

Poster-Disease-modifying Therapy

The Benefits of Azathioprine in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Systematic Review and Meta-Analysis

Background: MOGAD is an emerging inflammatory demyelination disorder of the central nervous system. AZA is one of the commonly used...

Read More

Poster-Disease-modifying Therapy

Comparable Ofatumumab Treatment Outcomes in Patients across Racial/Ethnic Groups in the Asclepios I/II and Apolitos Studies

Background: Ofatumumab is a fully human anti-CD20 monoclonal antibody approved by the FDA for treatment of adults with relapsing multiple...

Read More